3,4,3′-Tri-O-methylellagic acid as an anticancer agent: in vitro and in silico studies-Reference-Cited by-同舟云学术

3,4,3′-Tri-O-methylellagic acid as an anticancer agent: in vitro and in silico studies

Published:2022 Issue:46 Volume:12 Page:29884-29891
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Wardana Andika Pramudya¹²,Abdjan Muhammad Ikhlas²,Aminah Nanik Siti²³^ORCID,Fahmi Mochamad Zakki²^ORCID,Siswanto Imam²⁴,Kristanti Alfinda Novi²³^ORCID,Saputra Mirza Ardella⁵,Takaya Yoshiaki⁶

Affiliation:

1. PhD Student of Mathematics and Natural Sciences, Faculty of Science and Technology, Universitas Airlangga, Surabaya 60115, Indonesia

2. Department of Chemistry, Faculty of Science and Technology, Universitas Airlangga, Surabaya 60115, Indonesia

3. Biotechnology of Tropical Medicinal Plants Research Group, Universitas Airlangga, Indonesia

4. Bioinformatic Laboratory, UCoE Research Center for Bio-Molecule Engineering, Universitas Airlangga, Surabaya, Indonesia

5. Nanotechnology Engineering, Faculty of Advanced Technology and Multidiscipline, Universitas Airlangga, Surabaya 60115, Indonesia

6. Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku, Nagoya, 468-8503, Japan

Abstract

We report a natural product compound isolated from Syzygium polycephalum known as 3,4,3′-tri-O-methylellagic acid (T-EA) as a candidate drug for cancer treatment using in vitro and in silico approaches.

Funder

Universitas Airlangga

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/RA/D2RA05246F

Reference34 articles.

1. Multifactorial beliefs about the role of genetics and behavior in common health conditions: prevalence and associations with participant characteristics and engagement in health behaviors

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Targeting CDK9: a promising therapeutic opportunity in prostate cancer

4. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.